Emergent BioSolutions (EBS) Asset Utilization Ratio (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly Asset Utilization Ratio of 0.51 for Q1 2026, down 5.07% year-over-year from 0.54 in Q1 2025, and down 4.04% quarter-over-quarter from 0.53 in Q4 2025.
Emergent BioSolutions (EBS) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Emergent BioSolutions' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.51 for Q1 2026.
- In Q1 2026, Asset Utilization Ratio fell 5.07% year-over-year to 0.51; the TTM figure through Mar 2026 stood at 0.51 (down 5.07% YoY), while the FY2025 annual figure was 0.55, down 15.55% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.51, down from 0.53 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 0.65 in Q1 2024, with the low at 0.32 in Q1 2023.
- The 5-year median for Asset Utilization Ratio is 0.54 (2023), against an average of 0.53.
- The sharpest annual moves came in 2023 and 2024: Asset Utilization Ratio plunged 46.13% in 2023, then soared 104.61% in 2024.
- Emergent BioSolutions' Asset Utilization Ratio stood at 0.37 in 2022, then surged by 53.16% to 0.56 in 2023, then climbed by 3.61% to 0.59 in 2024, then decreased by 8.64% to 0.53 in 2025, then declined by 4.04% to 0.51 in 2026.
- Business Quant data shows EBS's Asset Utilization Ratio at 0.51 in Q1 2026, 0.53 in Q4 2025, and 0.55 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | 0.63 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.63 |
| Mar 31, 2026 | 0.51 |
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 0.55 |
| Jun 30, 2025 | 0.60 |
| Mar 31, 2025 | 0.54 |
| Dec 31, 2024 | 0.59 |
| Sep 30, 2024 | 0.62 |
| Jun 30, 2024 | 0.54 |
| Mar 31, 2024 | 0.65 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.54 |
| Jun 30, 2023 | 0.42 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.37 |
| Sep 30, 2022 | 0.54 |
| Jun 30, 2022 | 0.57 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 0.61 |
| Sep 30, 2021 | 0.56 |